DoJ signals SEP shift; German injunction regime change; US patent deals down; Trade secrets move up corporate agenda; Pharma portfolio M&A analysis; plus much more – IAM

DoJ signals SEP shift; German injunction regime change; US patent deals down; Trade secrets move up corporate agenda; Pharma portfolio M&A analysis; plus much more  IAM